{"entity":{"type":"insider","cik":"0001586226","url":"/insider/0001586226","json_url":"/insider/0001586226.json","name":"TZIANABOS ARTHUR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":18,"first":"2013-09-12","last":"2026-03-12","span_basis":"filed_date"},"name_variants":[{"name":"TZIANABOS ARTHUR","source":"filing","n_filings":18,"first_seen":"2013-09-12","last_seen":"2026-03-12"}],"transactions":[{"id":6149322,"accession":"0001586226-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001586226-26-000002","line_url":"/filing/0001586226-26-000002#line-2","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (Interim Executive Chair)","officer_title":"Interim Executive Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4355.0,"shares_display":"4,355","price_per_share":40.0033,"price_display":"40.00","price_state":"stated","total_value":174214.3715,"total_display":"174,214.37","shares_owned_after":31339.0,"shares_owned_after_display":"31,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-12","scope":"insider"},{"id":3021431,"accession":"0000950170-24-096986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-096986","line_url":"/filing/0000950170-24-096986#line-2","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":265.0,"shares_display":"265","price_per_share":24.2,"price_display":"24.20","price_state":"stated","total_value":6413.0,"total_display":"6,413.00","shares_owned_after":7983.0,"shares_owned_after_display":"7,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-08-14","scope":"insider"},{"id":2824351,"accession":"0000950170-24-015944","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-015944","line_url":"/filing/0000950170-24-015944#line-3","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13037.0,"shares_display":"13,037","price_per_share":0.5711,"price_display":"0.57","price_state":"stated","total_value":7445.4307,"total_display":"7,445.43","shares_owned_after":128778.0,"shares_owned_after_display":"128,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-02-15","scope":"insider"},{"id":7938933,"accession":"0000899243-23-001574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001574","line_url":"/filing/0000899243-23-001574#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10616.0,"shares_display":"10,616","price_per_share":1.3905,"price_display":"1.39","price_state":"stated","total_value":14761.548,"total_display":"14,761.55","shares_owned_after":108395.0,"shares_owned_after_display":"108,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6087458,"accession":"0000899243-22-001743","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-001743","line_url":"/filing/0000899243-22-001743#line-2","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5354.0,"shares_display":"5,354","price_per_share":3.7802,"price_display":"3.78","price_state":"stated","total_value":20239.1908,"total_display":"20,239.19","shares_owned_after":86011.0,"shares_owned_after_display":"86,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-12","scope":"insider"},{"id":4613441,"accession":"0001209191-21-013320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-013320","line_url":"/filing/0001209191-21-013320#line-2","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":60.6652,"price_display":"60.67","price_state":"stated","total_value":606652.0,"total_display":"606,652.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-23","scope":"insider"},{"id":2479089,"accession":"0001209191-20-060549","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-060549","line_url":"/filing/0001209191-20-060549#line-5","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10196.0,"shares_display":"10,196","price_per_share":45.971,"price_display":"45.97","price_state":"stated","total_value":468720.316,"total_display":"468,720.32","shares_owned_after":5504.0,"shares_owned_after_display":"5,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"},{"id":2479086,"accession":"0001209191-20-060549","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-060549","line_url":"/filing/0001209191-20-060549#line-4","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5294.0,"shares_display":"5,294","price_per_share":46.8472,"price_display":"46.85","price_state":"stated","total_value":248009.0768,"total_display":"248,009.08","shares_owned_after":210.0,"shares_owned_after_display":"210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"},{"id":2479082,"accession":"0001209191-20-060549","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-060549","line_url":"/filing/0001209191-20-060549#line-3","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":45.0787,"price_display":"45.08","price_state":"stated","total_value":193838.41,"total_display":"193,838.41","shares_owned_after":15700.0,"shares_owned_after_display":"15,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"},{"id":2479079,"accession":"0001209191-20-060549","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-060549","line_url":"/filing/0001209191-20-060549#line-2","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210.0,"shares_display":"210","price_per_share":47.6089,"price_display":"47.61","price_state":"stated","total_value":9997.869,"total_display":"9,997.87","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"},{"id":2725335,"accession":"0000899243-20-003246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-003246","line_url":"/filing/0000899243-20-003246#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":16.1617,"price_display":"16.16","price_state":"stated","total_value":202021.25,"total_display":"202,021.25","shares_owned_after":77505.0,"shares_owned_after_display":"77,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-05","scope":"insider"},{"id":2039375,"accession":"0000899243-20-000316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-000316","line_url":"/filing/0000899243-20-000316#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.4953,"price_display":"20.50","price_state":"stated","total_value":256191.25,"total_display":"256,191.25","shares_owned_after":90005.0,"shares_owned_after_display":"90,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-03","scope":"insider"},{"id":8580939,"accession":"0000899243-19-028394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-028394","line_url":"/filing/0000899243-19-028394#line-2","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":16.2541,"price_display":"16.25","price_state":"stated","total_value":203176.25,"total_display":"203,176.25","shares_owned_after":102505.0,"shares_owned_after_display":"102,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-03","scope":"insider"},{"id":8580938,"accession":"0000899243-19-028394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028394","line_url":"/filing/0000899243-19-028394#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":16.0447,"price_display":"16.04","price_state":"stated","total_value":200558.75,"total_display":"200,558.75","shares_owned_after":115005.0,"shares_owned_after_display":"115,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-29","filed_date":"2019-12-03","scope":"insider"},{"id":8091708,"accession":"0000899243-19-024657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-024657","line_url":"/filing/0000899243-19-024657#line-2","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12400.0,"shares_display":"12,400","price_per_share":17.3907,"price_display":"17.39","price_state":"stated","total_value":215644.68,"total_display":"215,644.68","shares_owned_after":127605.0,"shares_owned_after_display":"127,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-01","filed_date":"2019-10-02","scope":"insider"},{"id":8091705,"accession":"0000899243-19-024657","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-024657","line_url":"/filing/0000899243-19-024657#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.23,"price_display":"18.23","price_state":"stated","total_value":1823.0,"total_display":"1,823.00","shares_owned_after":127505.0,"shares_owned_after_display":"127,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-01","filed_date":"2019-10-02","scope":"insider"},{"id":8664784,"accession":"0000899243-19-022839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-022839","line_url":"/filing/0000899243-19-022839#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":18.7456,"price_display":"18.75","price_state":"stated","total_value":234320.0,"total_display":"234,320.00","shares_owned_after":140005.0,"shares_owned_after_display":"140,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8345637,"accession":"0000899243-19-020990","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-020990","line_url":"/filing/0000899243-19-020990#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":17.3689,"price_display":"17.37","price_state":"stated","total_value":217111.25,"total_display":"217,111.25","shares_owned_after":152505.0,"shares_owned_after_display":"152,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-05","scope":"insider"},{"id":8722895,"accession":"0000899243-19-019172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-019172","line_url":"/filing/0000899243-19-019172#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":18.984,"price_display":"18.98","price_state":"stated","total_value":237300.0,"total_display":"237,300.00","shares_owned_after":165005.0,"shares_owned_after_display":"165,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-03","scope":"insider"},{"id":8580718,"accession":"0000899243-19-015645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-015645","line_url":"/filing/0000899243-19-015645#line-1","is_derivative":false,"issuer_cik":"0001586226","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001586226","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":19.861,"price_display":"19.86","price_state":"stated","total_value":248262.5,"total_display":"248,262.50","shares_owned_after":177505.0,"shares_owned_after_display":"177,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-05","scope":"insider"},{"id":8822996,"accession":"0001179110-15-006172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-006172","line_url":"/filing/0001179110-15-006172#line-1","is_derivative":false,"issuer_cik":"0001544227","issuer_name":"OvaScience, Inc.","issuer_ticker":"OVAS","issuer_name_source":null,"issuer_url":"/issuer/0001544227","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Officer (President and CSO)","officer_title":"President and CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225.0,"shares_display":"225","price_per_share":28.77,"price_display":"28.77","price_state":"stated","total_value":6473.25,"total_display":"6,473.25","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-09","filed_date":"2015-04-09","scope":"insider"},{"id":8877869,"accession":"0001179110-15-006087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-006087","line_url":"/filing/0001179110-15-006087#line-1","is_derivative":false,"issuer_cik":"0001544227","issuer_name":"OvaScience, Inc.","issuer_ticker":"OVAS","issuer_name_source":null,"issuer_url":"/issuer/0001544227","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Officer (President and CSO)","officer_title":"President and CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175.0,"shares_display":"175","price_per_share":28.04,"price_display":"28.04","price_state":"stated","total_value":4907.0,"total_display":"4,907.00","shares_owned_after":175.0,"shares_owned_after_display":"175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-08","filed_date":"2015-04-08","scope":"insider"},{"id":4333448,"accession":"0001104659-13-069617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-069617","line_url":"/filing/0001104659-13-069617#line-1","is_derivative":false,"issuer_cik":"0001544227","issuer_name":"OvaScience, Inc.","issuer_ticker":"OVAS","issuer_name_source":null,"issuer_url":"/issuer/0001544227","owner_cik":"0001586226","owner_name":"TZIANABOS ARTHUR","owner_url":"/insider/0001586226","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.32,"price_display":"10.32","price_state":"stated","total_value":10320.0,"total_display":"10,320.00","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-12","filed_date":"2013-09-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623526","name":"Stoke Therapeutics, Inc.","url":"/issuer/0001623526","role":"Director, Officer (Interim Executive Chair)","n_filings":3,"first_seen":"2020-11-25","last_seen":"2026-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Q32 Bio Inc.","url":"/issuer/0001661998","role":"Director, Officer (President & CEO)","n_filings":12,"first_seen":"2019-06-05","last_seen":"2024-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001544227","name":"OvaScience, Inc.","url":"/issuer/0001544227","role":"Officer (President and CSO)","n_filings":3,"first_seen":"2013-09-12","last_seen":"2015-04-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586226","retrieved_at":"2026-08-22T03:17:31+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}